508 related articles for article (PubMed ID: 14598081)
1. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
Rabey JM; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn AD; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
Clin Neuropharmacol; 1997 Aug; 20(4):322-37. PubMed ID: 9260730
[TBL] [Abstract][Full Text] [Related]
3. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
van Hilten JJ; van der Zwan AD; Zwinderman AH; Roos RA
Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
[TBL] [Abstract][Full Text] [Related]
4. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
Stebbins GT; Goetz CG
Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
[TBL] [Abstract][Full Text] [Related]
5. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.
Forjaz MJ; Martinez-Martin P
Mov Disord; 2006 Nov; 21(11):1892-8. PubMed ID: 16958134
[TBL] [Abstract][Full Text] [Related]
6. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
Martínez-Martín P; Gil-Nagel A; Gracia LM; Gómez JB; Martínez-Sarriés J; Bermejo F
Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
8. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
9. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
[TBL] [Abstract][Full Text] [Related]
10. The clinically important difference on the unified Parkinson's disease rating scale.
Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
[TBL] [Abstract][Full Text] [Related]
11. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: Part I, feasibility, scaling assumptions, reliability, and precision.
Martinez-Martin P; Forjaz MJ
Mov Disord; 2006 Aug; 21(8):1182-8. PubMed ID: 16673397
[TBL] [Abstract][Full Text] [Related]
12. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version.
Carod-Artal FJ; Martinez-Martin P; Vargas AP
Mov Disord; 2007 Jan; 22(1):91-8. PubMed ID: 17094102
[TBL] [Abstract][Full Text] [Related]
13. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD).
Martínez-Martín P; Forjaz MJ; Cubo E; Frades B; de Pedro Cuesta J;
Mov Disord; 2006 Feb; 21(2):208-14. PubMed ID: 16161158
[TBL] [Abstract][Full Text] [Related]
14. Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?
Martínez-Martín P; Benito-León J; Alonso F; Catalán MJ; Pondal M; Tobías A; Zamarbide I
Mov Disord; 2003 Sep; 18(9):985-92. PubMed ID: 14502665
[TBL] [Abstract][Full Text] [Related]
15. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.
Ramaker C; Marinus J; Stiggelbout AM; Van Hilten BJ
Mov Disord; 2002 Sep; 17(5):867-76. PubMed ID: 12360535
[TBL] [Abstract][Full Text] [Related]
16. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure.
Martínez-Martín P; Benito-León J; Burguera JA; Castro A; Linazasoro G; Martínez-Castrillo JC; Valldeoriola F; Vázquez A; Vivancos F; del Val J; van Blercom N; Frades B
J Clin Epidemiol; 2005 Jul; 58(7):674-9. PubMed ID: 15939218
[TBL] [Abstract][Full Text] [Related]
17. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
Louis ED; Lynch T; Marder K; Fahn S
Mov Disord; 1996 Mar; 11(2):185-92. PubMed ID: 8684390
[TBL] [Abstract][Full Text] [Related]
18. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
LeWitt P; Oakes D; Cui L
Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
[TBL] [Abstract][Full Text] [Related]
19. Does the ADL part of the unified Parkinson's disease rating scale measure ADL? An evaluation in patients after pallidotomy and thalamic deep brain stimulation.
Hariz GM; Lindberg M; Hariz MI; Bergenheim AT
Mov Disord; 2003 Apr; 18(4):373-81. PubMed ID: 12671942
[TBL] [Abstract][Full Text] [Related]
20. Impact of the motor complications of Parkinson's disease on the quality of life.
Chapuis S; Ouchchane L; Metz O; Gerbaud L; Durif F
Mov Disord; 2005 Feb; 20(2):224-30. PubMed ID: 15384126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
